PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 71: Articles 35001-35500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Why can't I be me? A woman's argument for the ovulation method of birth control.
  2. Why natural family planning?
  3. Why some women prefer abortion to contraception.
  4. Withdrawal of ''high estrogenic'' contraceptive pills. [Tilbagetraekning af de ''hoyostrogene'' p-piller.]
  5. The world neighbours "total approach" in adult education and family planning.
  6. World survey of family planning services and practice.
  7. Worst form of birth control hurts women psyche.
  8. Youth and family planning information and education programmes for young people.
  9. Youth and family planning.
  10. Youth, communication and planned parenthood.
  11. Yugoslavia (Family planning)
  12. ] Kung hunter-gatherers: feminism, diet, and birth control.
  13. Birth control and the argument of saving and investment.
  14. Birth control, income redistribution, and the rate of saving: the case of Mexico.
  15. Cerebral embolism and oral contraceptives. (Letter to the editor)
  16. Contraceptive mechanism of microdose norethindrone.
  17. Effect of some contraceptive steroids upon the human spermatozoa.
  18. Female work, fertility, and contraceptive use in a biracial sample.
  19. The influence of oral contraceptive steroids on serum lipids.
  20. Injectable medroxyprogesterone acetate contraception: metabolic and endocrine effects.
  21. Postamenorrheic versus postpartum strategies of contraception.
  22. The revolution in birth control practices of U.S. Roman Catholics.
  23. Steroid contraceptives in the People's Republic of China.
  24. Use of Depo-Provera as a contraceptive during the puerperium. [Impeigo del Depo Provera a scopo anticoncezionale in puerperio.]
  25. Family planning programs and fertility patterns./Programmes de planning familial et schemas de fecondite./Programas de planejamento da família e padroes./Programas de planificacion familiar y patrones de fecundidad de fertilidade.
  26. The world's laws on voluntary sterilization for family planning purposes.
  27. Training and deployment of personnel for family planning education and services.
  28. Training and utilization of family planning nurse specialists.
  29. Training for trainers: programs for family planning training personnel.
  30. Training of family planning workers in Japan.
  31. Transcervical instillation of Quinacrine for female contraception.
  32. Treatment of anovulation after discontinuation of oral contraceptives.
  33. Treatment of anovulation after oral contraceptives.
  34. Treatment of secondary sterility with oral contraceptives.
  35. Trends in family planning acceptor characteristics in the Philippines, 1970-1972.
  36. Trytophan metabolism in oral contraceptive users and controls on defined intakes of Vitamin B6 [abstract]
  37. Tuberculosis control and family planning programme.
  38. Tumor organotropy of N-nitrosomethylurea under the influence of hormonal contraceptives.
  39. Turkey's new technique (Family planning slogans in cigarette packs)
  40. Two minutes with the oral contraceptives.
  41. Two types of contraceptives and their influence on endocrine balance. [Zwei Typen von Kontrazeptiva und deren Einfluss auf des endokrine Gleichgewicht.]
  42. Type contraception used, decision to abort appear unrelated.
  43. Types of systemic contraceptives.
  44. U.A.R.: influential factors in the acceptance of birth control and the consequential approaches to family planning.
  45. The U.S.N. Study: findings and implications for the family planning program of Bangladesh.
  46. Ultrasonic detection, localization and identification of intrauterine contraceptive devices.
  47. The ultrastructural effects of combined oral contraceptive regimen on stromal cells.
  48. Undesirable effects of steroid hormones in contraception. [Nezadouci ucinky steroidnich hormonu v antikoncepci.]
  49. UNICEF and family planning.
  50. UNIDO and family planning.
  51. United States aid to population/family planning in Asia. Report of a staff survey team to the Committee on Foreign Affairs, United States House of Representatives, 93rd Congress, February 25, 1973.
  52. The United States commitment to international family planning programs.
  53. Unmet needs in family planning.
  54. Unmet needs in family planning.
  55. Unmet needs in family planning. Background paper 1.
  56. Unmet needs in family planning: a first world survey of contraceptive services.
  57. Unmet needs in family planning: a world survey.
  58. Unmet needs in family planning: appendices. (Background paper and appendices, IPPF, 21st Anniversary Conference, Brighton, England, October 22-27, 1973)
  59. Until conception, contraception with Norinyl. (Advertisement) s on the serum gonadotropin levels in pre- and postmenopausal.
  60. Unwanted fertility and the use of contraception.
  61. Urban local bodies and the programme of family planning.
  62. Family planning study, Vol. 3. Contraceptive behavior and attitudes.
  63. Family planning study. Vol. 2. Research design and methodology.
  64. Family planning study. Vol. 3. Demographic characteristics. Sources of family planning service.
  65. Family planning study. Vol. 3: Chapter 3, Fertility behavior. Chapter 5, Community general health care.
  66. Family planning study: Vol. 1. Executive summary.
  67. Family planning study: Vol. 4. Data gathering instruments.
  68. A family planning survey in Halifax, Nova Scotia.
  69. Family planning technician: training and role of a new professional.
  70. Family planning themes and slogans (first draft)
  71. Family planning to become a way of life for the people of India.
  72. Family planning, birth control and attitudes toward sex. [Familienplanung, Empfaengnisregelung und Einstellungen zur Sexualitaet.]
  73. Family planning--changes in attitudes and practices among low income women between 1967 and 1970-71.
  74. Family planning-a matter of health.
  75. Family planning.
  76. Family planning.
  77. Family planning.
  78. Family planning. [4. Planificacion familiar.]
  79. Family planning. Mali: the pill plus tradition.
  80. Family planning: a guide to methods for fieldworkers, health, social and welfare workers.
  81. Family planning: an education program for adults.
  82. Family planning: differential performance of states.
  83. Family Planning: education and motivation for industrial workers.
  84. Family planning: hope for a nation.
  85. Family planning: solving one program's problems.
  86. Fasting serum lipids and serum lipoprotein distribution during oral contraceptive therapy in Nigerians.
  87. FDA okays limited use of injectable contraceptive.
  88. Feasibility of involving indigenous medicine practioners for family planning service delivery in Kerala, India.
  89. Family planning in the German Democratic Republic. [Familienplanung in der DDR.]
  90. Family planning in the immediate postpartum period.
  91. Family planning in the Mexican Institute of Social Security. [La planificacion familiar en el Instituto Mexicano del Seguro Social.]
  92. Family Planning in the Middle East and North Africa.
  93. Family planning in the National Health Service.
  94. Family planning in the organised sector: policy and program development.
  95. Family planning in the organized sector: policy and program.
  96. Family planning in the United States.
  97. Family planning in two psychiatric hospitals: a preliminary report.
  98. Family planning in West Malaysia: the triumph of economics and health over politics.
  99. Family planning information in the 1970's.
  100. Family planning issues in the United States.
  101. Family planning knowledge attitudes and practice.
  102. Family planning mothers' clubs in Korea.
  103. The family planning movement and population control.
  104. Family planning patterns: an experiment in describing modern fertility trends.
  105. Family Planning Payments. (Letter to the editor)
  106. Family planning policy--retrospect and prospect.
  107. Family planning program at McCormick Hospital, Chiang Mai.
  108. Family planning program evaluation system.
  109. Family planning program in Bangladesh: a review.
  110. Family planning program in India: an evaluation.
  111. The family planning program in Taiwan of family planning programs past, present and future.
  112. Family planning program in the medical education of the Colombian Association of Medical Schools.
  113. The family planning program in West Java. (A very brief report)
  114. The family planning programme in Nepal.
  115. Family planning programme: background paper.
  116. Family planning programmes and policy in India.
  117. Family planning programmes in Barbados.
  118. Family planning programmes in Jamaica.
  119. Family planning programmes in Trinidad and Tobago.
  120. Family planning programs in Latin America: a few characteristics of its past and future developments.
  121. Family Planning programs in world, national and individual perspectives. [Familieplanlegging i globalt, nasjonalt og individuelt perspektiv.]
  122. Family planning programs to stress quality, comprehensiveness, community participation.
  123. Modern contraception and its risks. [Die moderne Antikonzeption und ihre Risiken.]
  124. Moral aspects of birth control.
  125. More questions for better contraception. (Letter to the editor)
  126. Mothers Club plays pivotal role in Korean family planning.
  127. Motivation and technology in family planning programmes.
  128. Motivational determinants of family planning clinic attendance.
  129. MULT: a computer program designed to convert contraceptive history data into multiple segments of use or exposure.
  130. Multiple acceptors: a study of repetitive recording of clients as new acceptors in the Malaysian Family Planning Program.
  131. Multiple segment approach for the analysis of use-effectiveness of contraception.
  132. Myocardial infarction and oral contraceptives.
  133. Myocardial infarction and oral contraceptives.
  134. The Narangwal experiment on health and family planning.
  135. National Family Planning Forum sets program, reporting, manpower goals.
  136. National family planning programmes: an overview.
  137. The National Health Service (Family Planning) Amendment Act 1972 of 26 October 1972.
  138. The national population and family planning policy for the 10-year plan, 1973-1982.
  139. National reporting system for family-planning services.
  140. A natural development in oral contraception. (Advertisement)
  141. Natural family planning: the ovulation method.
  142. New birth control freedom for women.
  143. New Central's family planning programme: a case study of family planning work in "the organized sector."
  144. New forms of contraceptives won't be sold for 5-10 years.
  145. The new frontiers of contraceptives.
  146. New horizons in contraception.
  147. A new method of "natural" birth control.
  148. Newer approaches to steroidal contraceptives.
  149. Newer methods of contraception.
  150. Nicaraguan Demographic Association (E) (Asociacion Demografica Nicaraguense (E)): the role of commercial contraceptive distribution.
  151. Nine in 10 mid-Atlantic colleges offer no contraception: Boston schools do better.
  152. Nine in 10 of 3,500 newly delivered mothers adopt birth control in hospital.
  153. Non steroid pharmacological contraceptives in the male.
  154. Non-medical birth control. (Letter to the editor)
  155. Non-medical birth control: a neglected and promising field.
  156. Non-medical distribution of oral contraceptives. (Letter)
  157. Non-stop progestogen therapy for contraception.
  158. ''Intensive family planning program in three townships with a cafeteria type of offer'' or ''three-townships pilot pill study.'' Study 35.
  159. 1967 survey of doctors on practice in contraception and perforations of the uterus after loop insertion. Study 49.
  160. 25 effects of contraceptives on vascular system.
  161. 30 gamma): analyse des variations des taux des gonadotropineset des steroides. (Continuous oral contraception by d-Norgestrel (30 gamma): analysis of the variations in levels of gonadotropins and steroids. [Contraception orale continue par d-Norgestrel.]
  162. 6 years of contraception with intrauterine devices. [6 Jahre Kontrazeption mittels Intrauterinpessar.]
  163. Abortion and contraception: a review.
  164. Abortion in four Asian countries: patient characteristics, morbidity, and contraceptive acceptance.
  165. Abortion is an expensive contraceptive. [Aborter ar for dyra p-medel.]
  166. Abortion or contraceptives?) (Editorial. [Abort eller preventivmedel?]
  167. Abortion still ranks first in birth control.
  168. Abortion vs. contraception. (Letter to the editor)
  169. Abortion, contraception and child mental health.
  170. Abortion, fertility, and family planning in the Rostock district in the years 1962 to 1971. [Abortsituation, Fertilitat und Familienplanung im Bezirk Rostock in den Jahren 1962 bis 1971.]
  171. Accelerated hypertension secondary to oral contraceptives.
  172. Acceptability of contraceptive sterilization: psychosocial research approaches.
  173. Acceptability of the services. (Family planning)
  174. Accion Cultural Popular and family planning in Colombia.
  175. Accion Cultural Population and family planning in Colombia.
  176. Actual and potential contraceptive users in selected countries in 1971.
  177. Address. (Family planning in Bangladesh)
  178. Address. (Family Planning in the West Indies)
  179. Adenosine diphosphate-induced platelet aggregation in healthy women with and without a combined and a sequential contraceptive pill.
  180. Administration of a family planning service.
  181. Administration of family planning in Bihar.
  182. Administration of family planning programme in Maharashtra.
  183. Administration of family planning programme in Uttar Pradesh.
  184. The administration of family planning programs (Mexico)
  185. Administrators' perceptions of programs for information, education and communication concerning family planning in the Philippines and Malaysia: case study report No. 1.
  186. Adolescent sexuality: counseling, contraception, pregnancy.
  187. Adrenal-ovarian changes in rats on oral contraceptive agents.
  188. Advances in hormonal contraception.
  189. Advantage of low-dose oral contraception. [Interet des faibles dosages en contraception orale.]
  190. Advantages of voluntary sterilization: forces behind the rising demand. 1. Foolproof birth control.
  191. Advertising family planning in the U.S.A.
  192. Advertising family planning.
  193. Age at marriage and fertility (Implications for family planning)
  194. Age-parity trends in the Indonesian national family planning program 1971-1973.
  195. The "agricultural approach" (Family planning, Philippines)
  196. The aims and content of the curriculum for teaching family planning to medical students: report of a conference.
  197. Aims of family participation in a changing society as viewed through the national family planning programme: in India.
  198. Alleges MDs failing to provide optimal contraceptive advice.
  199. Alpha fetoprotein levels in women taking oral contraceptives.
  200. Alpha-2 pregnoglobulin (pregnancy-zone protein) - an estrogen-dependent macroglobulin elevated in pregnancy and oral contraception.
  201. Alpha-2 pregnoglobulin (pregnancy-zone protein): a unique macroglobulin elevated in pregnancy, contraception and cancer. (Abstract only))
  202. Alterations in mammary glandular epithelium following the use of oral contraceptives.
  203. Alternatives to the "pill" as a contraceptive method from the andrological viewpoint. [Alternativen zur "Pille" als Methoden der Antikonzeption aus andrologischer Sicht.]
  204. (Alza's uterine contraceptive system)
  205. Amenorrhea following use of combined oral contraceptives.
  206. Amenorrhoea after discontinuing combined oestrogen-progestogen oral contraceptives.
  207. Amenorrhoea after the use of oral contraceptives. (Letter to the editor)
  208. Analysis of the allocation of resources in family planning programs.
  209. Annual report 1972. (Family Planning in Taiwan)

     

  210. (Annual series of data on new acceptors of family planning services in 42 countries.)
  211. Annual summary of family planning services 1971.
  212. Anovulation following discontinuation of oral contraceptives.
  213. Anti-contraception laws in sub-Saharan Francophone African: sources and ramifications.
  214. Anti-estrogens and plasma proteins. II. Contraceptive drugs and estrogens.
  215. The Antigon-F and the Ypsilon intrauterine-contraceptive devices.
  216. The Antigon-F, a superior intrauterine contraceptive device.
  217. Antiovulatory contraception and phlebology. [Contraception anti-ovulatoire et phlebologie.]
  218. Antithrombin 3 and oestrogen content of oral contraceptives. (Letter to the editor)
  219. Antithrombin-3 and estrogen content of oral contraceptives. (Letter to the editor)
  220. Apoplexias in young women using oral contraceptives. [Schlaganfaelle junger Frauen by Einnahme von Ovulationshemmern.]
  221. The appearance of pregnancy-typical proteins during the use of hormonal contraceptives. [Zum Auftreten schwangerschaftstypischer Proteine unter der Verwendung hormonaler Kontrazeptiva.]
  222. Appendix 2: From "left" to "right" - A brief sketch of the philosophy and development of the birth control movement and its continuing role.
  223. Application of social science methodologies to information and education in family planning in IPPF-SEAOR.
  224. Application of the Massouras duck's foot intrauterine contraceptive device.
  225. Applied contraceptive research: international committee for contraceptive research.
  226. Are oral contraceptives carcinogenic for the breast? [Les contraceptifs sont-ils cancerogenes pour la glande mammaire de la femme?]
  227. Argentina (Family planning)
  228. Arkansas: State supports availability of contraceptives to all persons.
  229. Armistice on contraceptives.
  230. Army leads the way. (Family planning, Latin America)
  231. Aromatization of the A-ring of norethynodrel, a steroidal oral contraceptive, during trimethylsilylation.
  232. Assessment of family planning acceptability in the Philippines.
  233. Assessment of family planning programme effects on births: preliminary results obtained through direct matching of birth and programme acceptor records.
  234. The association between maternal ingestion of oral contraceptives and congenital malformations in subsequent offspring.
  235. The association between oral contraceptives and risk of developing cervical neoplasia in black women in a public family planning program.
  236. The association between the amount of copper on copper carrying IUDs and their contraceptive efficacy.
  237. The attitude of family planning workers.
  238. The attitude of Islam towards family planning.
  239. Attitudes concerning family planning in Iran. [Attitudes vis-a-vis du plan familial en Iran.]
  240. Attitudes of the Spanish woman toward family planning methods. [Actitudes de la mujer espanola hacia los metodos de planificacion familiar.]
  241. Attitudes on family planning: implications for developing communication-education strategies in Bangladesh family planning programs.
  242. Attitudes toward family planning and contraception in Mexico City.
  243. Attitudes toward family planning: a comparison between Northern and Southern black Americans: a preliminary report.
  244. Attitudes towards family planning in Ngeca village.
  245. Australia makes the family planning scene.
  246. Australia; knowledge, attitudes, and practice of family planning in Melbourne, 1971.
  247. Awareness, diffusion of information and reasons for adoption of vasectomy: a study of family planning in Bihar.
  248. Barriers to the diffusion of surgical contraception.
  249. Basic family planning research: rationale and implications for program and policy development.
  250. Battle of the contraceptives.
  251. Be brave and angry: chronicles of the International Planned Parenthood Federation.
  252. Behavior of antithrombin 3 with oral contraceptives. [Verhalten von Antithrombin 3 unter oralen Kontrazeptiva.]
  253. Behavior of serum ceruloplasmin during oral contraception. [Das Verhalten des Serumcoeruloplasmins unter oralen Kontrazeptiva.]
  254. Beliefs about birth control: a consistency theory analysis.
  255. Benefit-cost analysis of family planning.
  256. The benefits of birth control; Aberdeen's experience 1946-1970.
  257. Benign hepatomas and oral contraceptives. (Letter to the editor)
  258. Benign increase in intracranial pressure during oral contraception. (Abstract only)
  259. Benign intracranial hypertension during oral contraception. [Benigne intrakranielle Hypertension wahrend oraler Kontrazeption.]
  260. Bilan d'une consultation de contraception dans un service hospitalo-universitaire. (Evaluation of a contraception clinic in a university hospital department)
  261. Biological effectiveness of temperature rhythm birth control.
  262. Biological effects of oral contraceptive steroids.
  263. Birth control and the 1960 election.
  264. Birth control and the black American: a matter of genocide?
  265. Birth control and the policy process.
  266. Birth control clinic doing tubal fulguration.
  267. Birth control for men: vasectomy and other methods.
  268. Birth control handbook, 11th edition.
  269. Birth control held genocide by 39% of blacks in poll.
  270. The birth control pill and possible vitamin deficiencies.
  271. Birth control through sterilization. 1. Vasectomy: advantages and limitations.
  272. Birth control, income redistribution, and the rate of saving: the case of Mexico.
  273. Birth control: psychological effects of the sympto-thermal method. [Regulation des naissances: les effets psychiques de la methode sympto-thermique.]
  274. Birth control: current technology, future prospects.
  275. Birth defects and oral contraception.
  276. Birth defects and oral contraceptives. (Letter to the editor)
  277. Birth defects and oral contraceptives. (Letter to the editor)
  278. Birth interval and family planning.
  279. Blood platelet biochemistry in women receiving steroid contraceptives.
  280. Blood pressure, contraceptive pills, and natural sex hormones. [Blodtrykk, P-piller og naturlige kjonnssteroider.]
  281. The Bradford family planning service.
  282. A brief note about BEMFAM's national family planning seminars.
  283. British assessment. (Family planning services)
  284. Buddhism no deterrent to Thai family planning.
  285. By the London post: free contraception for all?
  286. C-Film: a new vaginal contraceptive.
  287. Campaign against venereal diseases and public control with contraceptive. [Kampagne mod knssygdomme og offentlig kontrol med praeservativer.]
  288. Can a woman who's unhappy with one contraceptive find happiness with another?
  289. Canadian experience with copper-covered intrauterine contraceptive devices.
  290. Cancer and hormonal contraception.
  291. Carcinoma in situ and carcinoma of the cervix during treatment with oral contraceptives. [Carcinoma in situ und Karzinom der Zervix unter Einnahme oraler Kontraze ptiva.]
  292. Cartaguan social security system: planning for expanded family planning clinic services.
  293. The case for both fundamental and applied studies in the search for new contraceptives.
  294. Case for free contraceptives.
  295. A case of intestinal infarct during treatment with oral contraceptives.
  296. A case of pregnancy and delivery following the placement of an intrauterine contraceptive spiral. [Sluchai na zabremenyavane i razhdane sled postavyane na v'trematochna antikontseptsionna spirala.]
  297. Case of pseudotumor of genitalia following long-term treatment with oral contraceptives. [Przypadek rzekomego guza narzadu rodnego po dlugotrwalym zazywaniu doustnych srodkow antykoncepcyjnych.]
  298. Categorize users of family planning help.
  299. The cause and management of symptoms associated with oral contraceptive pill use.
  300. Causes of failure of the temperature method of planned parenthood. [Priciny neuspechu teplotni metody planovaneho rodicovstvi.]
  301. Cellular effect of contraceptive medication.
  302. Census 1971--and the effect of family planning upon the growth rate of population.
  303. Center for disease control: annual summary of family planning services 1971.
  304. Cerebral arterial occlusive disease with telangiectasia associated with oral contraceptives.
  305. Cerebral disturbances related to the use of oral contraceptives. [Zerebrale Stoerungen im Zusammenhang mit dem Gebrauch von oralen Kontrazeptiva.]
  306. Cerebral infarct, pulmonary embolism and nonbacterial, nonrheumatic endocarditis associated with oral contraceptive, a case report. (Abstract only)
  307. Certain oral contraceptives may initiate or worsen acne.
  308. Cervical mucus conductivity changes during oral contraceptive use.
  309. Ceylon: continuing practice of contraception by acceptors of oral contraceptives and intrauterine devices in a field programme.
  310. Change in the gonadotropic function in rats during the use of the new Soviet contraceptive megestranol. [Izmenenie gonadotropnoi funktsii u krys pri primenenii novovo otechestve nnovo kontratseptivnovo sredstva megestranola.]
  311. Change in uterus size during oral contraception? [Aenderung der Uterusgroesse unter der Einnahme von oralen Kontrazeptiva?]
  312. Change strategies and their application to family planning programs.
  313. Changes in platelet thrombotic tendency during oral contraception.
  314. Changes in portio epithelium as a special secondary effect of oral contraceptives. [Veraenderungen des Portioepithels als eine spezielle Nebenwirkung oraler Kontrazeptiva.]
  315. Changes in serum Vitamin A levels during and after oral contraceptive therapy.
  316. Changes in the gingiva during therapy with hormonal contraceptives. [Zahnfleischveraenderungen unter kontrazeptiver Hormonbehandlung.]
  317. Changes in the heparinocyte count during the use of hormonal contraceptives. [Veraenderungen der Heparinozytenzahl bei Einnahme von hormonalen Kontrazeptiva.]
  318. Changes in the use of birth control methods.
  319. Changes in the use of oral contraceptives by Rhode Island women between 1967 and 1970.
  320. Changing moods in contraception.
  321. Changing patterns in cervical cytology among oral and non-oral contraceptive users.
  322. Chapter V: Responsibilities in contraceptive counseling.
  323. Characteristics of couples practicing the temperature/rhythm method of birth control.
  324. A checklist for evaluative overviews of family planning program activities.
  325. Chemical contraception: a new approach.
  326. Chemical methods of male contraception.
  327. Child health and family planning: an appeal to policy-planners.
  328. Children and contraceptive pills. What risk is there in accidental intake? [Barn og P-piller. Hvilken risiko er det ved aksidentalt inntak?]
  329. China's family planning: 'stunning'.
  330. Choices and challenges for the Federal family planning program.
  331. Cholestatic jaundice due to oral contraceptives. [Ictere cholestatique des contraceptifs oraux.]
  332. Cholestatic jaundice prolonged by oral contraceptives. [Ictericia colestasica prolongada por anticonceptivos orales.]
  333. Choosing the correct birth control pill: a scientific approach.
  334. Chromosomal and anatomic studies of pregnancies following the discontinuation of steroidal contraceptives. [Etudes chromosomiques et anatomiques des grossesses suivant l'arret de contraceptifs steroides.]
  335. Clinic discontinuation and contraceptive need.
  336. Clinical and epidemiologic aspects of oral contraceptive safety.
  337. Clinical and histological aspects of the nasal mucosa under the influence of oral contraceptives. [Aspects clinques et histologiques de la muqueuse nasale sous l'efft des contraceptifs oraux.]
  338. Clinical aspects of intrauterine contraceptive device (IUD) complications: a basis for Food and Drug Administration and Federal Trade Commission regulation of IUD research, production, and promotion.
  339. Clinical aspects of the efficiency of an oral contraceptive ethynodiol diacetate, bisecurin as a function of the estrogen component. [Kliniczne efekty doustnej antykoncepcji przy uzyciu dwoctanu ethynodiolu, preparat-bisecurin w zaleznosci od komponentu estrogennego.]
  340. Clinical assessment of a low-estrogen combined oral contraceptive.
  341. Clinical contraceptive case studies: findings and implications for Bangladesh Family Planning Program.
  342. The clinical delivery of family planning services in Costa Rica, 1973: country program description source document.
  343. Clinical effect of low dose lynestrenol as oral contraceptive.
  344. Clinical evaluation of a normophasic oral contraceptive.
  345. Clinical experience with mechanical and hormonal contraception. [Klinicke skusenosti s mechanichou a hormonal nou antikoncepciou.]
  346. Clinical experience with microdose D-norgestrel as an oral contraceptive.
  347. Clinical experience with the double coil intrauterine device at Family Planning Centers of Greater Los Angeles.
  348. Clinical experience with the LEM, an intrauterine contraceptive device.
  349. Clinical experience with two retroprogesterones in precoital contraception in women.
  350. Clinical studies of contraception at Ain Shams University.
  351. Clinical studies of lactation and contraception.
  352. Clinical study of a new normophasic type of oral contraceptive. [Etude clinique d'un nouveau contraceptif oral de type normophasique.]
  353. Clinical study of a new oral contraceptive: Ovostat. [Etude clinique d'un nouveau contraceptif oral: Ovostat.]
  354. Clinical trial and laboratory investigation of a low-dose progestogen-only contraceptive: Exluton.
  355. Clinical trial of a vaginal contraceptive--sodium cellulose polysulfate. [Etude clinique sur un contraceptif vaginal--natr. cellulos, trisulfur.]
  356. Clinical trial with the oral contraceptive Combiquens. [Essais cliniques avec le contraceptif oral Combiquens.]
  357. Colombia (Family planning)

     

  358. Combined oral contraceptives. [Les oestro-progestatifs.]
  359. Commentary: family planning need and the future of the family planning program.
  360. Commentary: Some policy and program implications of "Contraceptive Failure in the United States".
  361. Comments by the family planning association of British Columbia.
  362. Comments on the application of management science to family planning programs in the developing countries.
  363. Commercial contraceptive sales in Columbia, Iran and the Philippines.
  364. Commercial distribution of contraceptives in Afghanistan: actual and potential use of a marketing system for diffusion of innovation.
  365. Communication in support of population/family planning activities.
  366. Communication strategies for family planning.
  367. Communication strategies for Pakistan family planning programme.
  368. Communication-motivation strategy for family planning: a closer look at KAP.
  369. A communications research and evaluation design for the Korean Family Planning Program.
  370. The community based distribution of contraceptives: a handbook. (First draft)
  371. A community family planning program.
  372. The community-based distribution of family planning supplies: programmes and choices.
  373. Community-based family planning in Sarawak.
  374. A comparative clinical trial with 6 oral contraceptives.
  375. Comparative daily oral contraceptive study.
  376. Comparative studies of two oral contraceptives containing dl norgestrel and d norgestrel.
  377. Comparative study of Hall's ring and Lippes loop as intrauterine contraceptives. [Estudio comparativo del anillo de Hall y el asa de Lippes como anticonceptivos intrauterinos.]
  378. Comparative teratogenicity of contraceptive steroids in mice and rats. (Abstract only)
  379. A comparison of early and late adopters of family planning.
  380. A comparison of the changes in ovaries after use of oral contraceptive agents with normal ovaries and ovaries during pregnancy.
  381. Concentrations of unconjugated estrone, estradiol, androstenedione and testosterone in ovarian and peripheral venous plasma in women: the effects of steroid contraceptives.
  382. Concepts in organization of family planning programmes in developing countries.
  383. Condoms in Turkish family planning.
  384. Confidence in contraception.
  385. Consideration of the relationship between the compliance of some intrauterine contraceptive devices and the expulsion rates (first)
  386. Construction of single and multiple decrement life tables for the analysis of use-effectiveness of contraception.
  387. Consultation on the role of the traditional birth attendant in maternal and child health and family planning. Geneva, March 13-20, 1973: Report of review and analysis of information and data on traditional birth attendants.
  388. Consumers of Washington Heights Family Planning Center, New York City and community comparison women.
  389. Continuation and pregnancy rates with 4 contraceptive methods.
  390. Continuation et surveillance de la contraception. (Continuation and surveillance of contraception)
  391. Continuous low dose contraception with norethisterone acetate.
  392. Continuous microdose norethindrone vs. combined oral contraceptives.
  393. Contraception after abortion and post partum. An evaluation of risks and benefits of Oral contraceptives with emphasis on the relation of female sex hormones to thromboembolism and genital and breast cancer.
  394. Contraception after childbirth. [Empfangnisverhutung nach der Geburt.]
  395. Contraception after pregnancy. (Letter to the editor)
  396. Contraception and abortion. [Prevensjon og abort.]
  397. Contraception and family planning. A current responsibility of preventive medicine. With some critical thoughts on contraception, abortion, and birth control. [Empfangnisverhutung und Familienplanung, ein aktuelles Anliegen der prophylaktischen Medizin. Auch einige kritische Gedanken zur Kontrazeption, Abtreibung und Geburtenregelung.]
  398. Contraception and infertility.
  399. contraception and marital conflicts) [Contraception et malaise du couple.]
  400. Contraception and medical psychology. [Contraception et psychologie medicale.]
  401. Contraception and pregnancy: experience of young unmarried women in the United States.
  402. Contraception and vaccination against rubella.
  403. Contraception by immunization.
  404. Contraception clinic finds health needs.
  405. Contraception continuation.
  406. Contraception for adolescents.
  407. Contraception for minors. [Contraception chez les mineures.]
  408. Contraception for the needy. (Letter to the editor)
  409. Contraception for the needy. (Letter to the editor)
  410. Contraception for the needy. (Letter to the editor)
  411. Contraception from the gynecological viewpoint. [Empfangnisverhutung aus gynakologischer Sicht.]
  412. Contraception in a practice community.
  413. Contraception in general medicine. Technical, educational and sociological problems of family planning. [La contraception en medecine generale. Problemes techniques, educatifs et sociologiques du planning familial.]
  414. Contraception in Japan. [La contraception au Japon.]
  415. Contraception in nulliparas. [La contraception chez la nullipare.]
  416. Contraception in premenopause and during menopause) [Contraception en pre-menopause et en menopause.]
  417. Contraception in the Lords.
  418. Contraception in the Unani system of medicine and where we stand.
  419. Contraception through sealing of the fallopian tubes. [Preduprezhdenie beremennosti putem plombirovaniya matochnykh trub.]
  420. Contraception with intrauterine devices.
  421. Contraception with minipills.
  422. Contraception, sterilization, and abortion: legal interpretation of consent.
  423. Contraception.
  424. Contraception: a name from the past.
  425. Contraception: enter the mini-pills.
  426. Contraception: prospect of new contraceptives.
  427. The contraceptive action of the copper IUD in the rat.
  428. Contraceptive advice in connection with legal abortion. [Antikonceptionell radgivning i samband med legal abort.]
  429. Contraceptive alternatives to the pill from a gynecological point of view. [Alternative zur "Pille" als Methoden der Antikonzeption aus gynaekologischer Sicht.]
  430. Contraceptive and reproductive education. Section I: Anatomy and physiology of reproduction.
  431. Contraceptive choice and cervical cytology.
  432. Contraceptive conundrum. II. Hypertension.
  433. Contraceptive education for all teens, and services on request favored by most adults.
  434. Contraceptive effect of intrauterine application of Lugol's solution.
  435. Contraceptive effect of megestrol acetate implants. (Abstract only)
  436. Contraceptive failure in the United States.
  437. A contraceptive from the pineal gland?
  438. Contraceptive methods in Bangladesh.
  439. Contraceptive methods.
  440. Contraceptive motivation key to prescription.
  441. Contraceptive pills and hypertension. [P-piller och hypertension.]
  442. Contraceptive pills and liver damage - practical guide. [P-piller og leverskader - praktisk veiledning.]
  443. Contraceptive pills and measurement of blood coagulation. [P-pillen og maling af blodets koagulationsevne.]
  444. Contraceptive plant drugs.
  445. Contraceptive practice in Asia.
  446. Contraceptive practices of wives of obstetricians.
  447. Contraceptive preparations. [Antikoncepcni preparaty.]
  448. Contraceptive rat traps.
  449. A contraceptive social marketing experiment- the Kenya Kinga Program.
  450. Contraceptive social marketing: a PSI mid test market survey of Meru traders.
  451. Contraceptive sterilization as a grass roots response: a comparative view of the Puerto Rican and United States experience.
  452. Contraceptive sterilization: the doctor, the patient, and the United States Constitution.
  453. Contraceptive steroids and hypertension: an experimental model.
  454. Contraceptive steroids: modifications of carbohydrate and lipid metabolism.
  455. Contraceptive techniques.
  456. Contraceptive technology 1973-1974.
  457. Contraceptive technology alone said to be insufficient to limit population growth.
  458. Contraceptive technology.
  459. Contraceptive treatment with low doses of gestagen in cases with medical history of hepatosis of pregnancy.
  460. Contraceptive trends in Indonesia's developing family planning program 1972-1973.
  461. Contraceptive usage among teenagers.
  462. Contraceptive use and its impact on fertility.
  463. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days.
  464. Contraceptives a bother, but is abstinence any fun?
  465. Contraceptives and contraceptive advice. [Erfarenheter och asikter om preventivmedel.]
  466. Contraceptives and sex. [Anticoncezionali e sesso.]
  467. Contraceptives and stroke. (Letter to the editor)
  468. Contraceptives for men.
  469. Contraceptives for the world.
  470. Contraceptives in Graeco-Arabic medicine.
  471. Contraceptives on prescription.
  472. Contraceptives on the N.H.S.
  473. Contraceptives on the N.H.S.
  474. Contraceptives on the N.H.S.
  475. Contraceptives on the N.H.S.
  476. Contraceptives on the N.H.S. (National Health Service) (Letter to the editor)
  477. Contraceptives on the N.H.S. (National Health Service) (Letter to the editor)
  478. Contraceptives, thromboembolism and lipid metabolism.
  479. Contraceptives. [Contraceptivos.]
  480. Contraceptives: computerized reports.
  481. The contribution of family planning programs.
  482. Controlled trial of oral contraceptives in haemophilia.
  483. Conventional contraceptives in the National Population Planning Programme.
  484. Coping with family planning in a rural area.
  485. Copper and zinc levels in endometrium, cervical mucus and plasma in women using the Copper-T device for intrauterine contraception.
  486. Copper determination and localization in different morphologic components of human endometrium during the menstrual cycle in copper intrauterine contraceptive device wearers.
  487. Coronary thrombosis and oral contraceptives.
  488. Coronary thrombosis in young women on oral contraceptives: report of 2 cases and review of the literature.
  489. Correlates of birth control practices in India.
  490. Correlates of continuance in a family planning program.
  491. A cost benefit analysis of the Barbados family planning programme.
  492. A cost-effect analysis of a family planning program: findings of a quasi-experimental study.
  493. A cost-effectiveness analysis of family planning programs in the Philippines.
  494. Cost-effectiveness of family planning programme--variation by methods and by states.
  495. Costa Rica: measuring the demographic impact of family planning programs.
  496. Country statement, Turkey. Turkey's population policy and family planning activities.
  497. Couple-year of protection: a measure of family planning program output.
  498. A critical study of family planning work in Kalyanpur.
  499. Critics of black family planning seen ignoring gravidas' risks.
  500. Cryofibrinogen and oral contraception in women.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.